Trials / Sponsors / QurAlis Corporation
QurAlis Corporation
Industry · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in He Healthy Participant Study | Phase 1 | 2026-02-02 |
| Completed | A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants Healthy Volunteers | Phase 1 | 2025-01-10 |
| Completed | A Study Exploring the PK/PD Relationship of QRL-101 in Adults With ALS Amyotrophic Lateral Sclerosis | Phase 1 | 2024-11-11 |
| Completed | A 3-way Cross-over Study on the Effects of QRL-101 on Transcranial Magnetic Stimulation and Nerve Excitability Healthy | Phase 1 | 2024-10-07 |
| Completed | A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants Healthy Volunteers | Phase 1 | 2024-07-01 |
| Completed | A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants Healthy Volunteers | Phase 1 | 2022-12-22 |
| Active Not Recruiting | A Study Evaluating the Safety and Tolerability of QRL-201 in ALS Amyotrophic Lateral Sclerosis | Phase 1 | 2022-12-16 |